Our goal is to (1) asset-allocate optimally and (2) give the portfolio an extra push by focusing on major investment trends, particularly the "super-trends" aided by the world's recognition that the "externalities" are no longer external (see previous post, below).
One way to help accomplish both might be to invest further in the
agriculture trend,
via equities if investors are underweight equities generally, and
via commodities (the foodstuffs themselves) if investors are underweight inflation-beneficiaries.
We're attracted to agriculture as a way to help accomplish one's asset-allocation goals because we believe agriculture is one of the "super-trends" for the 21st century:
ag gives investors exposure to scarce resources that were until recently considered external, or near-costless -- arable land, fresh water, and a clean/disease-free environment. These scarce resources are becoming expensive and thus raising the cost of producing food, and ultimately food prices.
(We acknowledge risks of incorporating a major trend -- even one as broad as agriculture -- into one's asset allocation.
(1) A single class of commodities will be more volatile and have more ultimate downside risk than the broadest inflation hedge -- TIPS -- and also will not directly protect an investor's purchasing power beyond potentially his purchasing power of food. Any historical returns and correlation work I have seen regarding commodities refers to the broadest commodity indices, not a single commodity group. (2) A single sub-industry within equities can face high correlation with the overall equity market and more volatility. Therefore, we'd typically invest in major trends as relatively small supplement to an investor's core asset allocation.)
We like to think of investing in a super-trend in two ways:(1) invest in the scarce goods themselves; in this case, the agricultural commodities, and
(2) invest in the companies benefiting most from the world's need for more of those scarce goods; in this case, we'd highlight the crop yield-enhancing biotech companies.
The dual investment approach makes sense to us. An investment in
only #1, commodities, is a bet that human ingenuity won't solve the nature's scarcity and thus won't cause prices of commodities to fall. We hate to bet against billions of dollars of research and many thousands of the world's top scientists. At the same time, an investment in only #2, crop yield-enhancing companies, is a bet that competition among companies will remain subdued enough to permit continuing high profitability for the companies.
We want overall exposure to the super-trend, rather than a bet on nature versus technology. Also, an investment in both lets us keep score between nature's constraints on crop supply and technology's efforts to increase crop supply, a rivalry that will determine the performance of the overall investment trend.
Why invest long-term in agriculture commodities and equities in the first place? Some of the arguments are becoming well-known, and some may not be fully appreciated yet by investors:
(1) Developing market demographic shifts and wealth accumulation that are causing more consumption of meat, which is up to ten times more land-intensive than consuming grain,
(2) The global shift to Biofuels,
(3) Global warming and weather volatility trends that are making production of food less dependable,
(4) Less available fresh water in the form of predictable snowpack/rainfalls, and falling water tables,
(5) Land degradation due to soil erosion connected to over-use, salination, deforestation and other factors,
(6) Pollution, invasive species, new crop disease vectors and other factors,
(7) Higher production and transportation costs owing to fuel costs, and
(8) The lack of recognition of agriculture as an asset class until, in a very limited sense, the last year or so. We see this as potentially similar to how the institutional investment community viewed oil in 2003.
What are the long-term risks of investing in agriculture commodities and equities, generally?
(1) Rapid mitigation of trends sited above, such as global warming, soil degradation, water scarcity, the biofuels trend, etc (which we view as unlikely),
(2) A rapid conquest of technology over natural constraints in high-production areas that results in declining ag commodity prices, or at least higher penetration rates of ag biotech that effectively slows the growth rate for these companies and increases price competition among them. (We think this would take years to occur, and faces a moving target of changing conditions),
(3) A rapid application of new production techniques in current low-production areas. (We think most of that production would feed rising local populations rather than supply the world market.)
(4) Rapid increases of new acreage (which is difficult and expensive owing to required infrastructure developments),
(5) A rapid movement to free trade (but there is a countervailing trend to increase trade barriers instead to shield domestic farmers),
(6) A global recession and high demand elasticity (which could be a shorter-term issue rather than a long-term mitigation). Also recall that many of the risks are mitigated by owning not only the commodities but also the companies that would be responsible for raising output.
Securities - A VERY Brief Look
In
commodities, numerous ETFs and ETNs (strongly prefer ETNs in taxable accounts) track futures values for a wide variety of contracts. A commonly-cited ETF is Powershares DB Agriculture ETF (ticker: DBA), which tracks the corn, soybean, wheat and sugar futures. A popularly-cited ETN is the iPath Dow Jones AIG-Agriculture ETN (JJA).
In
equities, there are many ways to invest in agriculture, ranging from fertilizer companies to ag equipment makers. We're most interested in ag-biotech companies because of their ability to raise the barriers-to-entry by adding more and more biotech traits within seeds.
Among the ag-biotech companies, Monsanto (MON) and Syngenta (SYT) are two of the leaders with high exposure. Their largest U.S. and European competitors include Dow (DOW) AgroSciences, BASF (BASFY) Crop Protection, Bayer (BAYRY) CropScience, and DuPont (DD) Agriculture.
Monsanto filings acknowledge the likely long-term competition from Chinese and Indian ag-biotech efforts in particular. For example, a quick review of China's efforts in the area reveals billions of dollars of research efforts to build an industry in the past decade, nearly all government funded, with some movement toward private companies in the past few years. Origin Agritech Limited (SEED) is a NASDAQ-listed Chinese company, and YaSheng Group trades in pink sheets as YHGG. Agria (GRO), based in China, is partly an ag-biotech company. Taiwan is also becoming a large player biotech generally, with an ag-biotech subindustry.